Global Heparin Market: Trend Analysis and Forecast to 2022


Select Your License Type


samplerequest
makeanenquiry
download
Discount




Fig: Global Heparin Market Geographic Coverage and Analysis


Heparin is a Sulphur Containing Polysaccharide, used as an anticoagulant in the treatment of thrombosis. Heparin is an injectable blood thinner that primarily prevents the formation of blood clots and is produced in the body by basophils and mast cells. Moreover, it is used to prevent and treat deep vein thrombosis and pulmonary embolism, myocardial infarction and unstable angina. Heparin is usually stored within the secretory granules of mast cells and released only into the vasculature at sites of tissue injury. The global heparin market witnessed lucrative growth over the past few years owing to rising heart diseases and rapid lifestyle changes around the world. The global heparin market is projected to grow CAGR between 6.0% – 6.3% over the forecast period of 2016-2022 and expected to surpass USD 12 billion by 2022.

Globally, the heparin market is growing steadily due to increasing incidences of coagulation disorders, substantial growth in the number of the people suffering from diseases like Venous Thromboembolism (VTE), deep vein thrombosis and heart diseases. In addition, the considerable rise in the prevalence of the obesity is also expected to support the global growth of this market. However, stringent regulatory framework across different regions and side effects of the porcine heparin are likely to limit the global growth of heparin market. A heparin market is expected to experience adoption of synthetic heparin by leading players in the industry. With adoption of synthetic heparin, the global market is anticipated to augment the opportunities for the leading market player in the industry over the forecast period. Furthermore, Technological advancement and rising demand for heparin also expected to escalate growth in this market over the forecast period.

Segments Covered:

The report segments the global heparin market by type of product, route of administration, application, end users and regions. Product segment includes unfractionated heparin, low molecular weight heparin (LMWH) and ultra-molecular weight heparin (UMWH). Route of administration segment comprises IV injection, subcutaneous injection. The application segment includes Clinical trials, medical devices and venous Thromboembolism with the end user segment comprises hospital, blood and steam banks and others.

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. Asia pacific, North America and ROW are considered to be the prominent markets for heparin, whereas Asia pacific is expected to be the largest geographic segment growing at a CAGR from of XX% over the forecaste period. On the other hand, North America dominated the global market and registered as the highest revenue generating region in 2014.  The growth heparin market in North America region is attributed to the sophisticated healthcare infrastructure; increasing number of medical tourists and large number of surgical procedures conducted in the country.

Companies Profiled:

The companies covered in the report include

  • Sanofi SA
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Leo Pharma
  • Dr. Reddy’s Laboratories
  • Fresenius SE & Co. KG
  • Teva Pharmaceutical Industries Ltd.
  • Baxter International
  •  Aspen Holdings

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of heparin globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.  The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of heparin market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in heparin market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

The report also provides in depth analysis of regulatory framework pertaining to Heparin Market.This will help the companies to understand the regulatory compliances, supports, barriers in the Heparin market.  This section highlights key amendments and their implication on Heparin market in the short run as well as in the long run.This report will help manufacturers, suppliers and distributors of the heparin market to understand the present and future trends in this market and formulate their strategies accordingly.

1.    Report Overview

1.1    Report Description
1.2    Research Methods
1.3    Research Approaches

 

2.    Executive Summary

 

3.    Heparin Market Overview

3.1    Introduction
3.2    Market Dynamics
3.3    Drivers
3.4    Restraints
3.5    Opportunities
3.6    Challenges
3.7    Porter’s Five Forces Analysis
3.8    IGR – Growth Matrix Analysis
3.9    Competitive Landscape in the Heparin Market
3.10  Regulatory Framework analysis by region

3.10.1 North America
3.10.2 Europe
3.10.3 RoW (Including APAC, and LATAM)

 

4.    Global Heparin Market by Product Type (USD Million) 2015 – 2022

4.1    Introduction
4.2    Low Molecular Weight Heparin
4.3    Unfractionated Heparin
4.4    Ultra-low Molecular Weight Heparin

 

5.    Global Heparin Market by Route of administration (USD Million) 2015 – 2022

5.1     Introduction

5.2     IV injection
5.3     Subcutaneous injection

 

6.    Global Heparin Market by Application (USD Million) 2015 – 2022

6.1     Introduction

6.2     Clinical trials
6.3     Medical devices
6.4     Venous Thromboembolism

 

7.    Global Heparin Market by End User (USD Million) 2015 – 2022

7.1    Introduction
7.2    Hospitals
7.3    Blood and Stem Cell Bank
7.4    Others

 

8.    Global Heparin Market by Region, (USD Million) 2015 – 2022

8.1    Introduction
8.2    North America

8.2.1    North America Heparin Market by Type (USD Million)
8.2.2    North America Heparin Market by Route of administration (USD Million)

8.2.3    North America Heparin Market by Application (USD Million)

8.2.4    North America Heparin Market by End User (USD Million)

8.2.5    North America Heparin Market by Country (USD Million)

 

8.3    Europe

8.3.1    Europe Heparin Market by Type (USD Million)
8.3.2    Europe Heparin Market by Route of administration (USD Million)

8.3.3    Europe Heparin Market by Application (USD Million)

8.3.4    Europe Heparin Market by End User (USD Million)

8.3.5    Europe Heparin Market by Country (USD Million)

 

8.4    Asia Pacific

8.4.1    Asia Pacific Heparin Market by Type (USD Million)
8.4.2    Asia Pacific Heparin Market by Route of administration (USD Million)

8.4.3    Asia Pacific Heparin Market by Application (USD Million)

8.4.4    Asia Pacific Heparin Market by End User (USD Million)

8.4.5    Asia Pacific Heparin Market by Country (USD Million)

 

8.5    Latin America

8.5.1    Latin America Heparin Market by Type (USD Million)
8.5.2    Latin America Heparin Market by Route of administration (USD Million)

8.5.3    Latin America Heparin Market by Application (USD Million)

8.5.4    Latin America Heparin Market by End User (USD Million)

8.5.5    Latin America Heparin Market by Country (USD Million)

 

8.6    Rest of the World

8.6.1    RoW Heparin Market by Type (USD Million)
8.6.2    RoW Heparin Market by Route of administration (USD Million)

8.6.3    RoW Heparin Market by Application (USD Million)

8.6.4    RoW Heparin Market by End User (USD Million)

8.6.5    RoW Heparin Market by Country (USD Million)

 

9.    Leading Companies

9.1    Company Profiles

9.1.1    Sanofi SA
9.1.2    GlaxoSmithKline plc
9.1.3    Pfizer, Inc.
9.1.4    Leo Pharma
9.1.5    Dr. Reddy’s Laboratories
9.1.6    Fresenius SE & Co. KG
9.1.7    Teva Pharmaceutical Industries Ltd.
9.1.8    Baxter International
9.1.9    Aspen Holdings
9.1.10  Others


Got a Question?

If you have a question to ask our analyst, just fill this form and send it across, our representative will get in touch with you shortly.